Prentiss Smith & Co’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.15M Sell
131,596
-1,668
-1% -$61.9K 2.82% 12
2026
Q1
$5.34M Buy
133,264
+47,441
+55% +$2.25M 3.1% 10
2025
Q4
$3.86M Buy
85,823
+2,751
+3% +$127K 2.31% 18
2025
Q3
$3.71M Sell
83,072
-1,187
-1% -$56.8K 2.1% 20
2025
Q2
$4.05M Sell
84,259
-689
-0.8% -$30K 2.41% 15
2025
Q1
$3.41M Sell
84,948
-202
-0.2% -$8.5K 2.21% 19
2024
Q4
$3.9M Buy
85,150
+1,553
+2% +$69.5K 2.55% 16
2024
Q3
$3.92M Buy
+83,597
New +$3.81M 2.51% 16
2020
Q2
Sell
-104,405
Closed -$4.61M 73
2020
Q1
$4.61M Buy
+104,405
New +$4.08M 3.2% 12

Other funds holding QGEN

Prentiss Smith & Co's QGEN Position: Q2 2026 in Review

Prentiss Smith & Co reduced its Qiagen (QGEN) stake by 1.3% in Q2 2026, selling an estimated $61.9K and leaving 131,596 shares worth $5.15M. The position accounts for 2.82% of the portfolio, ranked #12.

Prentiss Smith & Co first reported a position in QGEN in Q1 2020 and has held it in 9 quarters since. The position peaked at $5.34M in Q1 2026. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Prentiss Smith & Co held 131,596 shares of Qiagen worth $5.15M as of Q2 2026.
  • Prentiss Smith & Co sold 1,668 Qiagen shares in Q2 2026, an estimated $61.9K.
  • Qiagen made up 2.82% of Prentiss Smith & Co's portfolio in Q2 2026, its #12 holding.
  • Prentiss Smith & Co first reported a position in Qiagen in Q1 2020 and has held it in 9 quarters since.
  • Prentiss Smith & Co's Qiagen position peaked at $5.34M in Q1 2026.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Prentiss Smith & Co's 13F filing for Q2 2026, filed 30 Jul 2026.